Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults

Atherosclerosis

Volumn 211, Issue 1, 2010, Pages 210-215

  Noel, Sabrina E ^a   Lai, Chao Qiang ^a   Mattei, Josiemer ^a   Parnell, Laurence D ^a   Ordovas, Jose M ^a   Tucker, Katherine L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

CD36; Hispanic; Metabolic syndrome; Puerto Rican

Indexed keywords

CD36 ANTIGEN;

ADULT; AGED; ARTICLE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PUERTO RICO; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; ETHNOLOGY; GENETICS; HISPANIC;

ADULT; ANTIGENS, CD36; BOSTON; HISPANIC AMERICANS; HUMANS; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE; PUERTO RICO;

EID: 77954314064     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.02.009     Document Type: Article

References (32)

1. US Census Bureau. Race and Hispanic Origin in 2003. Population Profile of the United States: Dynamic Version: 1-9; 2003.
2. Tucker K.L., Bermudez O.I., Castañeda C. Type 2 diabetes is prevalent and poorly controlled among Hispanic elders of Caribbean origin. Am J Public Health 2000, 90:1288-1293.
3. Lin H., Bermudez O.I., Falcon L.M., Tucker K.L. Hypertension among Hispanic elders of a Caribbean origin in Massachusetts. Ethn Dis 2002, 12:499-507.
4. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
5. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
6. Jeppesen J., Hansen T.W., Rasmussen S., Ibsen H., Torp-Pedersen C., Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007, 49:2112-2119.
7. Laaksonen D.E., Lakka H.M., Niskanen L.K., Kaplan G.A., Salonen J.T., Lakka T.A. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002, 156:1070-1077.
8. Gao X., Nelson M.E., Tucker K.L. Television viewing is associated with prevalence of metabolic syndrome in Hispanic elders. Diabetes Care 2007, 30:694-700.
9. Sale M.M., Woods J., Freedman B.I. Genetic determinants of the metabolic syndrome. Curr Hypertens Rep 2006, 8:16-22.
10. Corpeleijn E., van der Kallen C.J., Kruijshoop M., et al. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with Type 2 diabetes mellitus and insulin resistance. Diabet Med 2006, 23:907-911.
11. Love-Gregory L., Sherva R., Sun L., et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008, 17:1695-1704.
12. Ma X., Bacci S., Mlynarski W., et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004, 13:2197-2205.
13. Aitman T.J., Glazier A.M., Wallace C.A., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999, 21:76-83.
14. Pravenec M., Landa V., Zidek V., et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001, 27:156-158.
15. Rac M.E., Safranow K., Poncyljusz W. Molecular basis of human CD36 gene mutations. Mol Med 2007, 13:288-296.
16. Calvo D., Gomez-Coronado D., Suarez Y., Lasuncion M.A., Vega M.A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J Lipid Res 1998, 39:777-788.
17. Thorne R.F., Mhaidat N.M., Ralston K.J., Burns G.F. CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett 2007, 581:1227-1232.
18. Malhotra A., Elbein S.C., Ng M.C., et al. Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes. Diabetes 2007, 56:890-896.
19. Arya R., Blangero J., Williams K., et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002, 51:841-847.
20. Pravenec M., Kurtz T.W. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension 2007, 49:941-952.
21. Roden M., Price T.B., Perseghin G., et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996, 97:2859-2865.
22. Paffenbarger R.S., Hyde R.T., Wing A.L., Lee I.M., Jung D.L., Kampert J.B. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993, 328:538-545.
23. Lai C.Q., Tucker K.L., Choudhry S., et al. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet 2009, 125:199-209.
24. Excoffier L., Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
25. Kiens B., Roepstorff C., Glatz J.F., et al. Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol 2004, 97:1209-1218.
26. Ståhlberg N., Rico-Bautista E., Fisher R.M., et al. Female-predominant expression of fatty acid translocase/CD36 in rat and human liver. Endocrinology 2004, 145:1972-1979.
27. Lepretre F., Linton K.J., Lacquemant C., et al. Genetic study of the CD36 gene in a French diabetic population. Diabetes Metab 2004, 30:459-463.
28. Griffin E., Re A., Hamel N., et al. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 2001, 7:840-846.
29. Kashyap S.R., Ioachimescu A.G., Gornik H.L., et al. Lipid-induced Insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 2009.
30. Yamashita S., Hirano K., Kuwasako T., et al. Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. Mol Cell Biochem 2007, 299:19-22.
31. Bonen A., Parolin M.L., Steinberg G.R., et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 2004, 18:1144-1146.
32. Lan Q., Shen M., Garcia-Rossi D., et al. Genotype frequency and F ST analysis of polymorphisms in immunoregulatory genes in Chinese and Caucasian populations. Immunogenetics 2007, 59:839-852.